Creon Drug Information [ Solvay; Abbott; Algol Pharma; Altana Pharma; Bayer Schering Pharma; BJC Trading; Boehringer Ingelheim; Edward Keller; Grunenthal; Italmex; Nycomed; Perrigo; Sime Darby Marketing; Zuellig Pharma ]

Table of content

Creon category:

• Human

Active ingredients:

• Lipase
• Pancrelipase
• Protease

Creon companies and manufacturers:

• Solvay

• Abbott

• Algol Pharma

• Altana Pharma

• Bayer Schering Pharma

• BJC Trading

• Boehringer Ingelheim

• Edward Keller

• Grunenthal

• Italmex

• Nycomed

• Perrigo

• Sime Darby Marketing

• Zuellig Pharma

General Information

Creon forms, composition and dosages:

• Capsules, Delayed Release; Oral; Amylase 15,000 units; Lipase 3000 units; Protease 9500 units
• Capsules, Delayed Release; Oral; Amylase 30,000 units; Lipase 6000 units; Protease 19,000 units
• Capsules, Delayed Release; Oral; Amylase 60,000 units; Lipase 12,000 units; Protease 38,000 units
• Capsules, Delayed Release; Oral; Amylase 120,000 units; Lipase 24,000 units; Protease 76,000 units
• Capsules; Oral; Lipase 120,000 units; Pancrelipase 24,000 units; Protease 76,000 units
• Capsules; Oral; Lipase 30,000 units; Pancrelipase 6,000 units; Protease 19,000 units
• Capsules; Oral; Lipase 60,000 units; Pancrelipase 12,000 units; Protease 38,000 units

Indications, usages and classification codes:

• A09AA02 - Multienzymes (lipase, protease etc.)

• Creon analogs
• Creon similar